US Markets
BX

BioMed valued at $14.6 bln in deal for sale from one Blackstone fund to another

Blackstone Real Estate Partners and co-investors have agreed to sell BioMed Realty for $14.6 billion to a group led by existing BioMed investors, Blackstone Group Inc said on Thursday.

Oct 15 (Reuters) - Blackstone Real Estate Partners and co-investors have agreed to sell BioMed Realty for $14.6 billion to a group led by existing BioMed investors, Blackstone Group Inc BX.N said on Thursday.

Blackstone had agreed to buy BioMed Realty, a supplier of office space to healthcare companies, in late 2015 in a deal valued at $8 billion. (https://reut.rs/341V5a3)

Blackstone said on Thursday it is commencing a "go-shop" process on behalf of BioMed's current investors, with the recapitalization expected to close within five business days after the process concludes.

(Reporting by Kanishka Singh; Editing by Devika Syamnath)

((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BX

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More